MedPath
NMPA Approval

Doxofylline Injection

国药准字H20223695

September 30, 2022

Drug Information

多索茶碱注射液

注射剂

10ml:0.1g

化学药品

September 30, 2022

Company Information

Applicant Company

广西来宾市华侨区圣堂路419号(高新技术产业开发区)11号、16号标准厂房

Manufacturing Company

广西来宾市华侨区圣堂路419号(高新技术产业开发区)11号、16号标准厂房

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

多索茶碱注射液 - NMPA 批准文号 | MedPath